Literature DB >> 12434

Neurochemical changes following the administration of depleters of biogenic monoamines.

J D Lane, J E Smith, P A Shea, W J McBride.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 12434     DOI: 10.1016/0024-3205(76)90071-0

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


× No keyword cloud information.
  7 in total

1.  Tetrabenazine: for chorea associated with Huntington's disease.

Authors:  Lesley J Scott
Journal:  CNS Drugs       Date:  2011-12-01       Impact factor: 5.749

2.  Studies on the mechanism of the enhanced cold-induced TSH secretion in spontaneously hypertensive rats.

Authors:  J Mattila; P T Männistö; R K Tuominen
Journal:  Experientia       Date:  1983-04-15

3.  Role of vesicular monoamine transporter type 2 in rodent insulin secretion and glucose metabolism revealed by its specific antagonist tetrabenazine.

Authors:  Anthony Raffo; Kolbe Hancock; Teresa Polito; Yuli Xie; Gordon Andan; Piotr Witkowski; Mark Hardy; Pasquale Barba; Caterina Ferrara; Antonella Maffei; Matthew Freeby; Robin Goland; Rudolph L Leibel; Ian R Sweet; Paul E Harris
Journal:  J Endocrinol       Date:  2008-07       Impact factor: 4.286

4.  The treatment of severe dystonia in children and adults.

Authors:  C D Marsden; M H Marion; N Quinn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-11       Impact factor: 10.154

5.  Neurochemical changes in rat striatum and substantia nigra following drug administration : Evidence for an amino acid-dopamine-acetylcholine link.

Authors:  P J Roberts; H Kapur
Journal:  Neurochem Res       Date:  1977-10       Impact factor: 3.996

Review 6.  Dysregulation of Corticostriatal Connectivity in Huntington's Disease: A Role for Dopamine Modulation.

Authors:  Claudia Rangel-Barajas; George V Rebec
Journal:  J Huntingtons Dis       Date:  2016-12-15

7.  Tetrabenazine in the treatment of Huntington's disease.

Authors:  Diana Paleacu
Journal:  Neuropsychiatr Dis Treat       Date:  2007       Impact factor: 2.570

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.